Wall Street Journal - Nathan Becker - Jan 19, 2010
Sales of Lipitor and another Pfizer flagship drug, arthritis treatment Celebrex, have fallen recently amid fierce competition. Wall Street Expectations: The ...
Finally, it is facing patent expirations of its major blockbuster drugs like Lipitor ($12 billion of sales) and a few others that will hinder PFE's future ...